Skip to main content

PTC Symptoms Lead to Filing of Mirena IUD Lawsuit

PTC Symptoms Lead to Filing of Mirena IUD Lawsuit

PTC Symptoms Lead to Filing of Mirena IUD Lawsuit

Introduction

An increasing number of product liability lawsuits are filed against Bayer Healthcare, the maker of intrauterine birth control device Mirena. The lawsuits are filed by women who allege that the intrauterine device (IUD) maker failed to adequately warn the medical community and the end users about the associated risks.

Recently, a lawsuit was filed in the U.S. District Court for the Southern District of New York by a woman who raised similar allegations that the side effects of Mirena IUD caused blurred vision, severe headaches, back pains and other symptoms related to pseudotumor cerebri (PTC), or idiopathic intracranial hypertension (IIH) (a medical condition involving a dangerous build-up of fluid pressure around the brain) for which she had to be hospitalized and also undergo a diagnostic lumbar puncture .

A similar complaint was filed by a woman from Ohio in the U.S. District Court for the Southern District of New York, who claims the Mirena implant caused a dangerous build-up of fluid pressure on her optic nerves, resulting in papilledema, light sensitivity, blurred vision, headaches and other complications leaving her with a permanent injury.

This case will join the 200 plus centralized lawsuits involving pseudotumor cerebri or intracranial hypertension complications from Mirena IUDs filed against Bayer Healthcare as a part of MDL: 2767, established in April 2017, for coordinated pre-trial proceedings in the Southern District of New York, before Judge Paul A. Engelmayer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!